Kirin and Immunosens collaborate on self-testing service using urinary IgA to visualize immune status. Joint funding from Kirin and Global Brain Corporation.
In Tokyo and Osaka, Japan, Kirin Holdings Company, Limited and Immunosens Co., Ltd. have initiated a collaboration to develop a novel “Self-Testing Service” that aims to display an individual’s immune condition. With the support of the KIRIN HEALTH INNOVATION FUND, a corporate venture capital fund established in February 2023 in partnership with Global Brain Corporation, a prominent venture capital company in Japan, Kirin Holdings has invested in Immunosens. This partnership marks a significant step in the joint development of innovative healthcare solutions.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments